Physician profile
Paul Vitulli
NPI 1932142114
$62,995.93
in general payments reported to CMS, 2019-2025
20 companies · $15K in 2025
The $15K reported for 2025 was more than what 92% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,734 · 2020: $2,057 · 2021: $1,456 · 2022: $8,042 · 2023: $16K · 2024: $16K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $45K · Food and Beverage: $1,707.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $45,000.00 |
| Food and Beverage | $1,707.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $55,038.71 | 2019-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac, Venacure 1470 Pro |
| Cardiovascular Systems INC. | $2,248.61 | 2019-2023 | Diamondback Peripheral |
| Bard Peripheral Vascular, INC. | $1,708.40 | 2019-2025 | Venovo, Venclose Maven Catheter, Covera |
| Medtronic, INC. | $1,432.80 | 2021-2024 | Abre, Hawkone, Venaseal |
| Janssen Pharmaceuticals, INC | $864.93 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $422.67 | 2019-2025 | Varithena Administration Pack |
| Abbott Laboratories | $371.40 | 2019-2023 | Diamondback Peripheral |
| Catheter Precision, INC. Fka Ra Medical Systems, INC. | $213.05 | 2019 | |
| Janssen Scientific Affairs, LLC | $115.93 | 2021 | |
| Kerecis Limited | $114.98 | 2021 | |
| Avinger INC. | $100.10 | 2019-2020 | |
| Siemens Medical Solutions USA, INC. | $84.05 | 2020-2024 | Embozene |
| Venclose INC. | $82.77 | 2020 | |
| Medtronic Vascular, INC. | $73.98 | 2019-2020 | |
| Veryan Medical Incorporated | $28.03 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cordis US Corp. | $24.75 | 2022 | |
| Cashflow Solutions, LLC | $20.09 | 2024 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Baudax Bio INC. | $19.87 | 2020 | |
| Janssen Biotech, INC. | $16.86 | 2023 | Xarelto |
| Biotronik INC. | $13.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Vitulli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.